237 related articles for article (PubMed ID: 37501549)
21. Receptor tyrosine kinase inhibitors for the treatment of osteosarcoma and Ewing sarcoma.
Just MA; Van Mater D; Wagner LM
Pediatr Blood Cancer; 2021 Aug; 68(8):e29084. PubMed ID: 33894051
[TBL] [Abstract][Full Text] [Related]
22. Xenograft and genetically engineered mouse model systems of osteosarcoma and Ewing's sarcoma: tumor models for cancer drug discovery.
Sampson VB; Kamara DF; Kolb EA
Expert Opin Drug Discov; 2013 Oct; 8(10):1181-9. PubMed ID: 23844615
[TBL] [Abstract][Full Text] [Related]
23. Ewing Sarcoma of the Bone With EWS/FLI1 Translocation After Successful Treatment of Primary Osteosarcoma.
Yodoya N; Iwamoto S; Matsumine A; Azuma E; Toyoda H; Miura Y; Nakatani K; Imai H; Hirayama M; Komada Y
J Pediatr Hematol Oncol; 2017 Jan; 39(1):6-9. PubMed ID: 27918348
[TBL] [Abstract][Full Text] [Related]
24. A review of the past, present, and future clinical trials from the Children's Cancer Group.
Bergeron S
J Pediatr Oncol Nurs; 1998 Apr; 15(2):98-102. PubMed ID: 9597819
[No Abstract] [Full Text] [Related]
25. Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma.
Stegmaier K; Wong JS; Ross KN; Chow KT; Peck D; Wright RD; Lessnick SL; Kung AL; Golub TR
PLoS Med; 2007 Apr; 4(4):e122. PubMed ID: 17425403
[TBL] [Abstract][Full Text] [Related]
26. A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma.
Anderson PM; Bielack SS; Gorlick RG; Skubitz K; Daw NC; Herzog CE; Monge OR; Lassaletta A; Boldrini E; Pápai Z; Rubino J; Pathiraja K; Hille DA; Ayers M; Yao SL; Nebozhyn M; Lu B; Mauro D
Pediatr Blood Cancer; 2016 Oct; 63(10):1761-70. PubMed ID: 27362300
[TBL] [Abstract][Full Text] [Related]
27. The value of adjuvant chemotherapy in the management of sarcomas in children.
Donaldson SS
Cancer; 1985 May; 55(9 Suppl):2184-97. PubMed ID: 3884137
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the p16INK4, p14ARF, p15, TP53, and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcoma.
Tsuchiya T; Sekine K; Hinohara S; Namiki T; Nobori T; Kaneko Y
Cancer Genet Cytogenet; 2000 Jul; 120(2):91-8. PubMed ID: 10942797
[TBL] [Abstract][Full Text] [Related]
29. The 'other' bone sarcomas in Japan: a retrospective study of primary bone sarcomas other than osteosarcoma, Ewing sarcoma and chondrosarcoma, using data from the Bone Tumuor Registry in Japan.
Nagano A; Tsugita M; Nishimoto Y; Akiyama H; Kawai A
Jpn J Clin Oncol; 2021 Aug; 51(9):1430-1436. PubMed ID: 34105731
[TBL] [Abstract][Full Text] [Related]
30. Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411).
Schafer ES; Rau RE; Berg SL; Liu X; Minard CG; Bishop AJR; Romero JC; Hicks MJ; Nelson MD; Voss S; Reid JM; Fox E; Weigel BJ; Blaney SM
Pediatr Blood Cancer; 2020 Feb; 67(2):e28073. PubMed ID: 31724813
[TBL] [Abstract][Full Text] [Related]
31. Quantification of Translocation-Specific ctDNA Provides an Integrating Parameter for Early Assessment of Treatment Response and Risk Stratification in Ewing Sarcoma.
Krumbholz M; Eiblwieser J; Ranft A; Zierk J; Schmidkonz C; Stütz AM; Peneder P; Tomazou EM; Agaimy A; Bäuerle T; Hartmann W; Dirksen U; Metzler M
Clin Cancer Res; 2021 Nov; 27(21):5922-5930. PubMed ID: 34426444
[TBL] [Abstract][Full Text] [Related]
32. Omic approaches to pediatric bone sarcomas.
Tirtei E; Cereda M; De Luna E; Quarello P; Asaftei SD; Fagioli F
Pediatr Blood Cancer; 2020 Feb; 67(2):e28072. PubMed ID: 31736201
[TBL] [Abstract][Full Text] [Related]
33. Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial.
Italiano A; Mir O; Mathoulin-Pelissier S; Penel N; Piperno-Neumann S; Bompas E; Chevreau C; Duffaud F; Entz-Werlé N; Saada E; Ray-Coquard I; Lervat C; Gaspar N; Marec-Berard P; Pacquement H; Wright J; Toulmonde M; Bessede A; Crombe A; Kind M; Bellera C; Blay JY
Lancet Oncol; 2020 Mar; 21(3):446-455. PubMed ID: 32078813
[TBL] [Abstract][Full Text] [Related]
34. Ewing Sarcoma and Osteosarcoma Have Distinct Immune Signatures and Intercellular Communication Networks.
Cillo AR; Mukherjee E; Bailey NG; Onkar S; Daley J; Salgado C; Li X; Liu D; Ranganathan S; Burgess M; Sembrat J; Weiss K; Watters R; Bruno TC; Vignali DAA; Bailey KM
Clin Cancer Res; 2022 Nov; 28(22):4968-4982. PubMed ID: 36074145
[TBL] [Abstract][Full Text] [Related]
35. Assessment of resection margins in bone sarcoma treated by neoadjuvant chemotherapy: Literature review and guidelines of the bone group (GROUPOS) of the French sarcoma group and bone tumor study group (GSF-GETO/RESOS).
Gomez-Brouchet A; Mascard E; Siegfried A; de Pinieux G; Gaspar N; Bouvier C; Aubert S; Marec-Bérard P; Piperno-Neumann S; Marie B; Larousserie F; Galant C; Fiorenza F; Anract P; Sales de Gauzy J; Gouin F;
Orthop Traumatol Surg Res; 2019 Jun; 105(4):773-780. PubMed ID: 30962172
[TBL] [Abstract][Full Text] [Related]
36. Systemic therapy for osteosarcoma and Ewing sarcoma.
Meyers PA
Am Soc Clin Oncol Educ Book; 2015; ():e644-7. PubMed ID: 25993235
[TBL] [Abstract][Full Text] [Related]
37. The genomic landscape of pediatric Ewing sarcoma.
Crompton BD; Stewart C; Taylor-Weiner A; Alexe G; Kurek KC; Calicchio ML; Kiezun A; Carter SL; Shukla SA; Mehta SS; Thorner AR; de Torres C; Lavarino C; Suñol M; McKenna A; Sivachenko A; Cibulskis K; Lawrence MS; Stojanov P; Rosenberg M; Ambrogio L; Auclair D; Seepo S; Blumenstiel B; DeFelice M; Imaz-Rosshandler I; Schwarz-Cruz Y Celis A; Rivera MN; Rodriguez-Galindo C; Fleming MD; Golub TR; Getz G; Mora J; Stegmaier K
Cancer Discov; 2014 Nov; 4(11):1326-41. PubMed ID: 25186949
[TBL] [Abstract][Full Text] [Related]
38. [Preliminary report of combination chemotherapy including Arsenic trioxide for stage III osteosarcoma and Ewing sarcoma].
Guo W; Tang XD; Tang S; Yang Y
Zhonghua Wai Ke Za Zhi; 2006 Jun; 44(12):805-8. PubMed ID: 16889724
[TBL] [Abstract][Full Text] [Related]
39. The significance of surveillance imaging in children with Ewing sarcoma and osteosarcoma.
Brekke SG; Lucke A; Hasle H; Baad-Hansen T
Pediatr Hematol Oncol; 2024 May; 41(4):273-282. PubMed ID: 38345039
[TBL] [Abstract][Full Text] [Related]
40. Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group Bone Tumor Committee.
Meyer JS; Nadel HR; Marina N; Womer RB; Brown KL; Eary JF; Gorlick R; Grier HE; Randall RL; Lawlor ER; Lessnick SL; Schomberg PJ; Kailo MD
Pediatr Blood Cancer; 2008 Aug; 51(2):163-70. PubMed ID: 18454470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
